OPEN LABEL STUDY OF LONG-TERM SAFETY OF ALTU-135- OUTPATIENT STUDY

ALTU-135 长期安全性的开放标签研究 - 门诊研究

• 批准号: 7950758
• 负责人: Leslie Hendeles
• 金额: $ 0.22万
• 依托单位: UNIVERSITY OF FLORIDA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950758
• 关键词: Age; Child; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Enrollment; Female; Funding; Grant; Institution; Outpatients; Patients; Protocols documentation; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Upper arm; Withdrawal; cystic fibrosis patients; male; open label

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The study described in this protocol is an open-label, single arm trial which will evaluate the long-term safety and tolerability of ALTU-135 treatment in patients with CF-related exocrine PI. The study will be conducted at multiple CF centers and each patient will participate for 12 months. Approximately 200 male and female patients with CF-related exocrine PI will be enrolled into the study, including at least 20 children ages 7-11 years. Assuming a withdrawal rate of 20% during the first 6 months and 20% during the second 6 months, 160 patients will complete 6 months of the study and 128 patients will complete the full 1-year.

这个子项目是众多研究子项目之一